Adjunctive Surgery Is Often Without Oncological Benefit at Time of Postchemotherapy Retroperitoneal Lymph Node Dissection.
Tim NestlerPia PaffenholzDavid PfisterJustine SchochAlessandro NiniAndreas HiesterPeter AlbersAxel HeidenreichPublished in: The Journal of urology (2023)
This study shows that 33% to 40% of all resections of adjacent organs do not harbor teratoma or viable GCT. This highlights the need for better patient selection for these complex patients.
Keyphrases
- end stage renal disease
- robot assisted
- minimally invasive
- rectal cancer
- ejection fraction
- newly diagnosed
- chronic kidney disease
- radical prostatectomy
- lymph node
- peritoneal dialysis
- case report
- squamous cell carcinoma
- patient reported outcomes
- coronary artery disease
- radiation therapy
- sentinel lymph node
- atrial fibrillation
- neoadjuvant chemotherapy